Feasibility, Acceptability, and Preliminary Effects of Lymfit (Lymfit)
Cancer Survivors, Lymphoma
About this trial
This is an interventional supportive care trial for Cancer Survivors focused on measuring Cancer survivorship, Quality of Life, Motivation, Physical Activity
Eligibility Criteria
Inclusion Criteria:
- Newly diagnosed lymphoma patients who received an initial diagnosis at the age of 18 to 39
- Receiving or have received chemotherapy with curative intent within the past six months
- Own a smartphone that is able to download the Fitbit application
- Have an internet connection at home that supports participation in coaching sessions via videoconferencing and the ability to complete the study questionnaires online
- Proficient in either French or English
Exclusion Criteria:
1) Have any contra-indications to moderate to vigorous levels of exercise
Sites / Locations
- Jewish General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Lymfit intervention
Wait-list control arm
Participants randomized to the intervention group will be allocated a pre-registered Inspire II model Fitbit. The kinesiologist will design a personalized exercise prescription for the participant. The kinesiologist will follow up with the participants every 2 weeks for 3 months to discuss their progress and to modify or advance their exercise prescriptions as needed.
The control group participants will begin receiving the Lymfit intervention 3 months after they sign the consent form.